Medications for Triple Negative Breast Neoplasms

2 results

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    Keytruda is a PD-1-blocking immunotherapy indicated for numerous cancers including melanoma, non-small cell lung cancer, head and neck cancer, bladder cancer, colorectal cancer, gastric cancer, cervical cancer, renal cell carcinoma, endometrial carcinoma, triple-negative breast cancer, and other solid tumors.
    Medication Details
    Drug Interactions

  • trodelvy - sacituzumab govitecan powder, for solution

    (Sacituzumab Govitecan)
    Gilead Sciences, Inc.
    Trodelvy treats unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) in adults - as first-line therapy (alone or with pembrolizumab for PD-L1-positive tumors) or second-line or later - and HR-positive, HER2-negative breast cancer after endocrine and two or more systemic therapies.
    Medication Details
    Drug Interactions